Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2009-08-12

FDA Approved: INFED — Supplemental Application (Allergan, Inc.)

View source ↗

Summary

FDA approved Allergan's supplemental application for INFED (iron dextran), resulting in changes to the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • INFED (iron dextran)

Snippet

SUPPL AP for INFED (IRON DEXTRAN)